Grevelding Pete, Hrdlicka Henry Charles, Holland Steve, Cullen Lorraine, Meyer Amanda, Connors Catherine, Cooper Darielle, Greco Allison
Milne Institute for Healthcare Innovation, Gaylord Specialty Healthcare, Wallingford, CT, United States.
Clinical and Medical Services, Gaylord Specialty Healthcare, Wallingford, CT, United States.
JMIR Rehabil Assist Technol. 2022 Feb 10;9(1):e31502. doi: 10.2196/31502.
With the continuation of the COVID-19 pandemic, shifting active COVID-19 care from short-term acute care hospitals (STACHs) to long-term acute care hospitals (LTACHs) could decrease STACH census during critical stages of the pandemic and maximize limited resources.
This study aimed to describe the characteristics, clinical management, and patient outcomes during and after the acute COVID-19 phase in an LTACH in the Northeastern United States.
This was a single-center group comparative retrospective analysis of the electronic medical records of patients treated for COVID-19-related impairments from March 19, 2020, through August 14, 2020, and a reference population of medically complex patients discharged between December 1, 2019, and February 29, 2020. This study was conducted to evaluate patient outcomes in response to the holistic treatment approach of the facility.
Of the 127 total COVID-19 admissions, 118 patients were discharged by the data cutoff. At admission, 29.9% (38/127) of patients tested positive for SARS-CoV-2 infection. The mean age of the COVID-19 cohort was lower than that of the reference cohort (63.3, 95% CI 61.1-65.4 vs 65.5, 95% CI 63.2-67.8 years; P=.04). There were similar proportions of males and females between cohorts (P=.38); however, the proportion of non-White/non-Caucasian patients was higher in the COVID-19 cohort than in the reference cohort (odds ratio 2.79, 95% CI 1.5-5.2; P=.001). The mean length of stay in the COVID-19 cohort was similar to that in the reference cohort (25.5, 95% CI 23.2-27.9 vs 29.9, 95% CI 24.7-35.2 days; P=.84). Interestingly, a positive correlation between patient age and length of stay was observed in the COVID-19 cohort (r=0.05; P=.02), but not in the reference cohort. Ambulation assistance scores improved in both the reference and COVID-19 cohorts from admission to discharge (P<.001). However, the mean assistance score was greater in the COVID-19 cohort than in the reference cohort at discharge (4.9, 95% CI 4.6-5.3 vs 4.1, 95% CI 3.7-4.7; P=.001). Similarly, the mean change in gait distance was greater in the COVID-19 cohort than in the reference cohort (221.1, 95% CI 163.2-279.2 vs 146.4, 95% CI 85.6-207.3 feet; P<.001). Of the 16 patients mechanically ventilated at admission, 94% (15/16) were weaned before discharge (mean 11.3 days). Of the 75 patients admitted with a restricted diet, 75% (56/75) were discharged on a regular diet.
The majority of patients treated at the LTACH for severe COVID-19 and related complications benefited from coordinated care and rehabilitation. In comparison to the reference cohort, patients treated for COVID-19 were discharged with greater improvements in ambulation distance and assistance needs during a similar length of stay. These findings indicate that other patients with COVID-19 would benefit from care in an LTACH.
随着新冠疫情的持续,将新冠病毒感染(COVID-19)的积极治疗从短期急性护理医院(STACHs)转移到长期急性护理医院(LTACHs),可以在疫情关键阶段减少STACH的人口普查数量,并最大限度地利用有限资源。
本研究旨在描述美国东北部一家LTACH中急性COVID-19阶段及之后患者的特征、临床管理和患者结局。
这是一项单中心组间比较回顾性分析,研究对象为2020年3月19日至2020年8月14日因COVID-19相关损伤接受治疗的患者的电子病历,以及2019年12月1日至2020年2月29日出院的病情复杂的参考人群。本研究旨在评估该机构整体治疗方法对患者结局的影响。
在127例COVID-19入院患者中,截止数据时118例患者出院。入院时,29.9%(38/127)的患者SARS-CoV-2感染检测呈阳性。COVID-19队列的平均年龄低于参考队列(63.3岁,95%置信区间61.1 - 65.4岁,而参考队列为65.5岁,95%置信区间63.2 - 67.8岁;P = 0.04)。队列间男女比例相似(P = 0.38);然而,COVID-19队列中非白人/非高加索患者的比例高于参考队列(优势比2.79,95%置信区间1.5 - 5.2;P = 0.001)。COVID-19队列的平均住院时间与参考队列相似(25.5天,95%置信区间23.2 - 27.9天,而参考队列为29.9天,95%置信区间24.7 - 35.2天;P = 0.84)。有趣的是,在COVID-19队列中观察到患者年龄与住院时间呈正相关(r = 0.05;P = 0.02),而在参考队列中未观察到。从入院到出院,参考队列和COVID-19队列的行走辅助评分均有所改善(P < 0.001)。然而,出院时COVID-19队列的平均辅助评分高于参考队列(4.9,95%置信区间4.6 - 5.3,而参考队列为4.1,95%置信区间3.7 - 4.7;P = 0.001)。同样,COVID-19队列的步态距离平均变化大于参考队列(221.1英尺,95%置信区间163.2 - 279.2英尺,而参考队列为146.4英尺,95%置信区间85.6 - 207.3英尺;P < 0.001)。入院时接受机械通气的16例患者中,94%(15/16)在出院前脱机(平均11.3天)。75例入院时饮食受限的患者中,75%(56/75)出院时恢复正常饮食。
在LTACH接受治疗的大多数重症COVID-19及相关并发症患者受益于协调护理和康复。与参考队列相比,接受COVID-19治疗的患者在相似住院时间内出院时,行走距离和辅助需求有更大改善。这些发现表明,其他COVID-19患者在LTACH接受治疗会受益。